STAT+: FDA approves new breast cancer drug, providing new option for some patients, boost for Roche

The FDA approved a new breast cancer drug from Roche, teeing up the launch of a medicine the company has said could become its top-selling product ever.
This is a brief. The reporting belongs to STAT — read the complete story, with full context and credits, at the source.
Read the full story at STAT ↗statnews.com
More from the Health desk
Just in

Pope concludes South America homecoming, reassures faithful after cancer scare

STAT+: Federal judge issues final ruling blocking U.S. plan to limit visa length for grad students, postdocs

DR Congo Ebola outbreak still out of control six months on, Africa CDC warns

STAT+: In a win for MAHA, FDA creates new regulatory category for the supplement NAC
